XM1CT6ICD-11 MMS 2026-01
Protein kinase inhibitors
Index terms
- Protein kinase inhibitors
Child codes
XM0601– RegorafenibXM0853– RuxolitinibXM09W7– AcalabrutinibXM0C70– IbrutinibXM0J75– OlmutinibXM0JZ7– MasitinibXM0SL6– RidaforolimusXM14D3– CeritinibXM15D6– DacomitinibXM16Z9– EntrectinibXM1982– SunitinibXM1FM4– LapatinibXM1HB8– DabrafenibXM1L31– QuizartinibXM1UG8– PralsetinibXM21J7– RociletinibXM28Z0– FedratinibXM2DD8– BrigatinibXM2LF4– LarotrectinibXM2QS0– CediranibXM2RL4– RibociclibXM2U80– CrizotinibXM3420– ErlotinibXM3A37– GefitinibXM3W52– VandetanibXM3YP5– BinimetinibXM4A57– SorafenibXM4BT2– GilteritinibXM4EA3– NintedanibXM4FT3– PazopanibXM4JL2– AlectinibXM4K70– PalbociclibXM4TL0– CabozantinibXM50U1– DasatinibXM55B8– VemurafenibXM59V9– LorlatinibXM5MT6– NeratinibXM5RQ2– EncorafenibXM5W30– ImatinibXM5Y46– MidostaurinXM60L5– BosutinibXM69S5– EverolimusXM6BP0– NilotinibXM6JL9– AxitinibXM6K99– CobimetinibXM70G2– PonatinibXM7168– AsciminibXM7380– PacritinibXM74A3– SelpercatinibXM7917– AfatinibXM7VJ9– TrametinibXM7ZH9– LenvatinibXM8B31– TivozanibXM8E34– AbemaciclibXM8YD2– OsimertinibXM93U4– TemsirolimusXM9L11– IcotinibXM9U75– InfigratinibXM9XE8– Futibatinib
Sibling codes
Foundation entity
Protein kinase inhibitors – http://id.who.int/icd/entity/6720716
Part of: XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes